Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Rachael L. Fleurence"'
Publikováno v:
JAMA. 329:1251
This Viewpoint introduces a proposed 5-year program from the Biden-Harris administration that would use direct-acting antivirals to eliminate hepatitis C in the United States.
Autor:
Bruce J. Tromberg, Richard J. Hodes, Tara A. Schwetz, Rachael L. Fleurence, Rick A. Bright, Francis S. Collins, Eliseo J. Pérez-Stable, Richard P. Woychik
Publikováno v:
The New England Journal of Medicine
New England Journal of Medicine
New England Journal of Medicine
RADx — Rapid Scaling Up of Covid-19 Testing In April 2020, Congress appropriated $1.5 billion to the NIH to increase national testing capacity for SARS-CoV-2. The NIH established the Rapid Accelera...
Autor:
Jeffrey Shuren, Rachael L. Fleurence
Publikováno v:
Clinical Pharmacology and Therapeutics
Autor:
Rachael L. Fleurence, Joe V. Selby
Publikováno v:
Value in Health. 23:287-288
Publikováno v:
The Journal of pediatrics. 214
Publikováno v:
JAMA cardiology. 4(3)
Autor:
Jason Gerson, Rachael L. Fleurence, Kelly M. Dunham, Robin P. Newhouse, Danielle Whicher, Bryan R Luce
Publikováno v:
Medical Care
Currently, there is wide-spread recognition that much of health care is insufficiently grounded in evidence as to what works for whom under what circumstances. An important reason for this is that research efforts often do not compare alternative opt
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes, 7(5), 787-792. LIPPINCOTT WILLIAMS & WILKINS
What is the drug of choice for condition x? is among the most commonly asked questions in primary care.1 Reflecting the complexity of prescribing decisions, answering this question requires a difficult trade-off between the benefits and harms of mult
Autor:
Jeffrey S. Brown, Lesley H. Curtis, Joe V. Selby, Rachael L. Fleurence, Richard Platt, Robert M. Califf
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA
The Patient-Centered Outcomes Research Institute (PCORI) has launched PCORnet, a major initiative to support an effective, sustainable national research infrastructure that will advance the use of electronic health data in comparative effectiveness r
Publikováno v:
Health Affairs. 33:1212-1219
The era of big data, loosely defined as the development and analysis of large or complex data sets, brings new opportunities to empower patients and their families to generate, collect, and use their health information for both clinical and research